Real-time enrollment status for this metastatic colorectal cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:39 AM UTC
| NCT Number | NCT07549412 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Colorectal Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,020 participants |
| Active Locations | 18 sites in the US |
| Sponsor | EMD Serono Research & Development Institute, Inc. |
| Last Updated on CT.gov | August 14, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT07549412 is currently recruiting participants. This phase3 study for metastatic colorectal cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by EMD Serono Research & Development Institute, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07549412 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07549412 was last updated 1 week ago (August 14, 2026). HelloStudys verifies this status automatically.